DE SCR159

Proclaims May 2024 as "Cystic Fibrosis Awareness Month" in Delaware.

Identifies cystic fibrosis as an inherited chronic disease affecting approximately 40,000 children and adults in the United States and over 70,000 worldwide.

Notes that life expectancy for people with cystic fibrosis born between 2018 and 2022 is predicted to be 56 years, a significant improvement from the 1950s when few children lived to elementary school age.

Highlights FDA approvals of new treatments including lumacaftor/ivacaftor (2018) and Trikafta triple combination therapy (2019).

Directs presentation of a copy of the resolution to the Cystic Fibrosis Foundation.